Our Score

7.7/10

From$299/mo

TypeBoth

InsuranceNo

Rank#22 of 48

Brand-nameCompoundedUpdated April 2026

By Iacob Pastina · Independent Editor

MEDVi Review (2026): Compounded GLP-1 with Oral + Injectable

Name: MEDVi GLP-1 Program
Brand: MEDVi
Price: 299 USD
Availability: InStock
Rating: 7.7 (1 reviews)

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Independently researched. Every statistic links to a primary source (NEJM, JAMA, FDA, CMS, or the provider's official disclosures). Affiliate links do not influence scoring or recommendations. Last verified April 2026.

Visit MEDVi

Summarize this article with

ChatGPT Perplexity Gemini Claude

MEDVi scores 7.7/10 in our independent review, starting at $299/mo for brand-name and compounded GLP-1 medications. MEDVi carves out a niche by offering both oral and injectable compounded semaglutide — a combination most competitors don't provide. If you're needle-averse but want to eventually transition to injectables (which generally show better bioavailability), MEDVi lets you do that within one platform.

What makes it different: The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients.

At a glance

Get MEDVi if

Needle-averse users who want to start with oral and potentially transition to injectable
Patients with GI sensitivity who want micro-dosing below standard protocols
Users who value a sleek digital experience with progress tracking

Skip if

Users who want brand-name FDA-approved Wegovy or Zepbound (MEDVi added Ozempic in 2026 but not Wegovy/Zepbound)
Those who need insurance billing
Patients who want a long, established track record (MEDVi launched 2023)

MEDVi Pros and Cons

What We Like

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

What Could Be Better

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

What it costs

Headline pricing, full-year math, and how MEDVi compares to the closest alternatives.

Quick facts

Monthly Cost

From $299/mo

Consultation

Included

Availability

All 50 States

Insurance

Not Accepted

Shipping

Free

Cancellation

Cancel anytime with 7-day no...

All pricing tiers

Injectable Semaglutide (first month)

$179/mo

Introductory first-month rate for injectable compounded semaglutide

Injectable Semaglutide (ongoing)

$299/mo

Ongoing monthly rate for injectable compounded semaglutide

Oral Semaglutide Tablets (first month)

$249/mo

Introductory first-month rate for oral compounded semaglutide

Oral Semaglutide Tablets (ongoing)

$369/mo

Ongoing monthly rate for oral compounded semaglutide

Compounded Tirzepatide (first month)

$279/mo

Introductory first-month rate for compounded tirzepatide (injectable or oral)

Compounded Tirzepatide (ongoing)

$399/mo

Ongoing monthly rate for compounded tirzepatide

Brand-name Ozempic

$1999/mo

FDA-approved Ozempic cash price — added in 2026

Cancellation policy: Cancel anytime with 7-day notice

How MEDVi works

Health Assessment + Preference Selection

Complete your health profile and indicate your preference for oral tablets or injectable semaglutide. MEDVi's intake specifically addresses needle concerns and GI sensitivity.

Provider Consultation + Micro-Dose Option

Your provider reviews your profile and can start you at micro-doses below standard protocols if you're concerned about side effects. Oral or injectable — your choice.

Treatment + Progress Tracking

Medication ships free. Track your weight, side effects, and milestones through MEDVi's patient portal. Transition from oral to injectable anytime.

Medications available

Semaglutide (compounded injectable)Semaglutide (compounded oral tablets)Tirzepatide (compounded injectable, added 2026)Tirzepatide (compounded oral tablets, added 2026)Ozempic (brand-name, added 2026)

Ready to check MEDVi's pricing for yourself?

Visit MEDVi

Is MEDVi legit?

Six trust signals, how we checked them, and what's been updated since the last review.

Common questions

Questions readers ask about MEDVi, similar providers to compare, and quick tools.

Frequently Asked Questions

How effective is oral compounded semaglutide vs. injectable?+

Injectable semaglutide generally has higher bioavailability than oral forms. Clinical data shows injectable produces slightly more weight loss on average. However, oral is a reasonable starting point for needle-averse patients, and MEDVi makes it easy to transition to injectable later.

What is micro-dosing and how does it work?+

Micro-dosing starts you at a lower dose than standard protocols (e.g., 0.125mg instead of 0.25mg for injectable). This can reduce initial GI side effects like nausea. Your provider gradually increases the dose based on your tolerance.

Can I switch from oral to injectable mid-treatment?+

Yes, and this is one of MEDVi's key features. Request the switch through your portal, and your provider adjusts your prescription. The price stays the same — no additional fees for the transition.

Does MEDVi offer tirzepatide?+

Yes — as of the 2026 expansion. MEDVi now offers both compounded tirzepatide (injectable and oral tablet, $279 first month / $399 ongoing) and compounded semaglutide. The 2026 lineup added tirzepatide alongside the existing semaglutide formats and brand-name Ozempic.